CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Combination Therapy for the Treatment of Central Nervous System Malignancies: Clinical Effectiveness and Guidelines

Last updated: February 8, 2019
Project Number: RB1308-000
Product Line: Rapid Response
Research Type: Devices and Systems
Report Type: Summary of Abstracts
Result type: Report

Question

  1. What is the clinical effectiveness of combination therapy for the treatment of patients with central nervous system malignancies?
  2. What are the evidence-based guidelines associated with the use of combination therapy for the treatment of patients with central nervous system malignancies?

Key Message

Three non-randomized studies were identified regarding combination therapy for the treatment of central nervous system malignancies.